Home / People / Thomas Louvel

Thomas Louvel


CMS Francis Lefebvre Avocats
2 rue Ancelle
92522 Neuilly-sur-Seine
Languages English, French

He has joined CMS Francis Lefebvre Avocats in 2017. He advises on the taxation of companies, groups of companies and their managers as well as on the taxation of transactions and private equity.

He also advises entrepreneurs, shareholders and managers on their personal and patrimonial tax issues.

His main fields of practice in respect of French and foreign multinational group companies cover:

  • the leading of tax audits, and then structuring, negotiation and optimization of external growth transactions (leveraged buy-out transactions, share and asset purchase agreements, management-packages);
  • internal restructuration of group companies (tax consolidation, mergers and partial contribution of assets);
  • assistance of group companies in their annual reporting process;
  • tax controversy with respect to taxpayers before the French tax authorities and tax courts.

Relevant operation:

  • BIOGROUP, tax advisor regarding the acquisition of the group, the Belgium medical biology group MEDINA (October 2020) ;
  • BIOGROUP, tax advisor regarding the acquisition of LABORIZON group (July 2020);
  • BIOGROUP, tax advisor regarding the acquisitions of UNILIANS, BIOESTEREL, BIOLITTORAL, DYOMEDEA (2019) ;
  • SERMETA, tax advisor regarding the financial restructuring of the group (2019) ;
  • NUMALLIANCE, tax advisor of the restructuring of the group (2019). 
more less


  • Master of business and tax law (DJCE) from the Jean Moulin Lyon III University (2014);
  • Paris Bar School (2017).
more less


  • Hauts-de-Seine Bar admission.
more less


  • Application of ATAD the new general interest limitation - First experiences – Lettre du Financement (November 2020) ;
  • Hit-parade 2020 of the difficulties met regarding the application of ATAD the new general interest limitation– Option Finance (September 2020) ;
  • « GAP ou pas GAP ? » : impact of the new tax standards related to the share purchase agreement writing – Lettre des Fusions-Acquisitions et du Private Equity (June 2019).
more less


Show only
CMS, Al­len & Overy, Lath­am & Watkins, De­groof Petercam, EY and Roth­schild...
Biogroup has ac­quired the CMA-Med­ina group, the lead­er in med­ic­al bio­logy in Bel­gi­um.This first ac­quis­i­tion out­side France will al­low Biogroup to cre­ate a European play­er po­si­tioned to pur­sue its ex­pan­sion...